SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-024361
Filing Date
2020-04-14
Accepted
2020-04-14 16:28:23
Documents
2
Period of Report
2020-04-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1605
2 POA DOCUMENT poa.txt EX-24.3_909913 2616
  Complete submission text file 0001209191-20-024361.txt   5706
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Issuer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FOUNDATION MEDICINE, INC. 150 SECOND STREET CAMBRIDGE MA 02141
Business Address
Civik Thomas (Reporting) CIK: 0001723092 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36070 | Film No.: 20791604